The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients

Journal of Wound Care
L GileadA Ingber

Abstract

To summarise our experience of the use of medicinal maggots for the debridement of necrotic chronic wounds and to try and identify prognostic factors for debridement success and associated pain. During the years 1996–2009, 723 wounds of 435 patients (180 females and 255 males) were treated with maggot debridement therapy (MDT) in 16 departments and units of the Hadassah Hospital in Jerusalem, Israel. Overall, 261 patients were treated during hospitalisation, while 174 were treated as ambulatory patients. In 90.5% of the patients the wounds were located on the leg, but only 48.0% had diabetic foot ulcers. The wound duration range from one to 240 months (mean=8.9; median=4 months). Sterile maggots of the green bottle fly, Lucilia sericata, were used for MDT. In 90.6% of the cases, maggots were placed directly on the wound using a cage-like dressing and left for 24 hours, while in 9.4% of the patients maggots concealed in a tea-bag like polyvinyl netting were used. The concealed maggots were left on the wound for 2–3 days. The number of treatments was 1–48 (mean=2.98; median=2) and the duration of the treatment varied between one and 81 days (mean=4.65; median=3). In 357 patients (82.1%) complete debridement of the wound was achie...Continue Reading

References

Apr 1, 1995·The Journal of Spinal Cord Medicine·R A ShermanM Vulpe
Apr 1, 1995·Journal of the American Podiatric Medical Association·S R StoddardR M Sherman
Mar 1, 1996·Archives of Dermatology·R A ShermanR Sullivan
Jan 1, 1996·The American Journal of Tropical Medicine and Hygiene·R A Sherman, F A Wyle
Feb 1, 1996·Journal of Wound Care·S ThomasS Jones
Nov 5, 1998·Diabetes Care·K Y MumcuogluI Raz
Aug 3, 1999·Acta Dermato-venereologica·H Wolff, C Hansson
Sep 16, 1999·International Journal of Dermatology·K Y MumcuogluI Raz
Mar 31, 2000·Journal of the Royal Society of Medicine·M CourtenayT J Ryan
Nov 14, 2001·American Journal of Clinical Dermatology·K Y Mumcuoglu
Aug 23, 2002·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Ronald A Sherman
Mar 26, 2003·Clinical and Experimental Dermatology·H Wolff, C Hansson
Oct 12, 2005·Advances in Skin & Wound Care·Pascal SteenvoordeJacques Oskam
Dec 23, 2006·International Journal of Dermatology·P SteenvoordeJ Oskam
Jan 19, 2008·Annals of the Royal College of Surgeons of England·Pascal SteenvoordeJacques Oskam
Mar 24, 2009·BMJ : British Medical Journal·Jo C DumvilleUNKNOWN VenUS II team

❮ Previous
Next ❯

Citations

Jul 17, 2015·International Wound Journal·David I PritchardWilhelm Jung
May 3, 2016·Advances in Wound Care·Rúben F Pereira, Paulo J Bártolo
Nov 12, 2016·British Journal of Nursing : BJN·Ruth Dickinson
Aug 14, 2012·Journal of Wound Care·K Y MumcuogluL Gilead
Dec 6, 2014·British Journal of Community Nursing·Eric Shi, David Shofler
May 19, 2020·Journal of Wound Care·Przemysław LipińskiMichał Mik
Nov 17, 2019·Medicina·Aurelio Perez-FavilaIdalia Garza-Veloz
Jan 31, 2020·Orbit·Mohsen Bahmani KashkouliMeysam Maleki
Sep 18, 2020·Advances in Skin & Wound Care·José Moya-LópezElvira De Luna-Bertos
Nov 5, 2019·International Wound Journal·Olga von BeckerathBenjamin Juntermanns
Aug 4, 2021·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Fatma Kubra Tombulturk, Gonul Kanigur-Sultuybek

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation
amputations

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.